Effect of cupping on respiratory symptoms of COVID-19
Phase 3
Recruiting
- Conditions
- COVID-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20200428047229N3
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Patients aged 18 to 60 years
Diagnosis confirmation by the cooperative infectious disease specialist in the project
Patient's consent to participate in the project
With inpatient clinical criteria (fever above 38° C or severe cough or shortness of breath or respiratory rate more than 24 per minute or oxygen saturation lower than 93%)
Positive PCR
Exclusion Criteria
Current incidence of coagulopathy, obesity, deep vein thrombosis, vertebral fracture or herniated disc
Need for current hospitalization in ICU
Pregnancy
Breastfeeding
Hearth failure
Chronic renal failure
Receive chemotherapy
Receive corticosteroids
Immune deficiency
Open wound at the site of cupping
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dyspnea. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of cupping. Method of measurement: By using a pulse oximeter and asking the patient.
- Secondary Outcome Measures
Name Time Method